Corbus Pharmaceuticals Holdings Shares Outstanding 2013-2019 | CRBP

Corbus Pharmaceuticals Holdings shares outstanding from 2013 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Corbus Pharmaceuticals Holdings Annual Shares Outstanding
(Millions of Shares)
2018 56
2017 50
2016 41
2015 31
2014 20
2013 7
2012 7
Corbus Pharmaceuticals Holdings Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 65
Q2 2019 69
Q1 2019 62
Q4 2018 56
Q3 2018 57
Q2 2018 57
Q1 2018 56
Q4 2017 50
Q3 2017 50
Q2 2017 50
Q1 2017 46
Q4 2016 41
Q3 2016 44
Q2 2016 39
Q1 2016 38
Q4 2015 31
Q3 2015 35
Q2 2015 27
Q1 2015 26
Q4 2014 20
Q3 2014 26
Q2 2014 22
Q1 2014 7
Q4 2013 7
Q3 2013 7
Q2 2013 7
Q1 2013 5
Q4 2012
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.367B $0.005B
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.224B 39.46
Takeda Pharmaceutical (TAK) Japan $59.662B 10.57
Astellas Pharma (ALPMY) Japan $32.195B 16.08
Eisai (ESALY) Japan $22.957B 44.26
Merck (MKGAF) Germany $17.215B 23.49
Grifols, S.A (GRFS) Spain $17.058B 22.35
Neurocrine Biosciences (NBIX) United States $9.668B 268.59
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.682B 35.72
Ionis Pharmaceuticals (IONS) United States $8.661B 17.54
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.741B 9.89
IPSEN SA ADR (IPSEY) France $6.419B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.269B 16.03
United Therapeutics (UTHR) United States $4.651B 0.00
Evotec AG (EVTCY) Germany $4.226B 68.30
Arrowhead Pharmaceuticals (ARWR) United States $4.122B 76.51
FibroGen (FGEN) United States $3.911B 114.92
Nektar Therapeutics (NKTR) United States $3.879B 0.00
PTC Therapeutics (PTCT) United States $3.597B 0.00
Sage Therapeutics (SAGE) United States $3.555B 0.00
ChemoCentryx (CCXI) United States $2.834B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.798B 11.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.200B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.089B 61.81
Xencor (XNCR) United States $2.035B 61.85
Heron Therapeutics (HRTX) United States $1.903B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.898B 23.27
Tilray (TLRY) Canada $1.719B 0.00
USANA Health Sciences (USNA) United States $1.570B 16.42
Corcept Therapeutics (CORT) United States $1.563B 18.99
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.436B 9.80
Theravance Biopharma (TBPH) Cayman Islands $1.409B 0.00
Endo (ENDP) Ireland $1.349B 2.48
Zogenix (ZGNX) United States $1.327B 0.00
Akebia Therapeutics (AKBA) United States $1.093B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.069B 33.12
Portola Pharmaceuticals (PTLA) United States $1.058B 0.00
Karyopharm Therapeutics (KPTI) United States $1.026B 0.00
Dermira (DERM) United States $1.022B 0.00
Radius Health (RDUS) United States $0.920B 0.00
ImmunoGen (IMGN) United States $0.919B 0.00
Aerie Pharmaceuticals (AERI) United States $0.881B 0.00
Collegium Pharmaceutical (COLL) United States $0.775B 0.00
TherapeuticsMD (TXMD) United States $0.656B 0.00
Flexion Therapeutics (FLXN) United States $0.622B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.540B 0.00
Molecular Templates (MTEM) United States $0.537B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.529B 64.13
Ardelyx (ARDX) United States $0.524B 0.00
Translate Bio (TBIO) United States $0.480B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.476B 20.53
Aptorum Group (APM) Hong Kong, SAR China $0.448B 0.00
Innate Pharma SA (IPHYF) France $0.442B 0.00
Organogenesis Holdings (ORGO) United States $0.436B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.434B 0.00
Recro Pharma (REPH) United States $0.399B 0.00
Siga Technologies (SIGA) United States $0.391B 8.93
Calithera Biosciences (CALA) United States $0.390B 0.00
DURECT (DRRX) United States $0.385B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.377B 0.00
Harpoon Therapeutics (HARP) United States $0.372B 0.00
Lannett Co Inc (LCI) United States $0.366B 5.88
Indivior (INVVY) United States $0.360B 2.14
Rafael Holdings (RFL) United States $0.328B 0.00
Concert Pharmaceuticals (CNCE) United States $0.326B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.314B 0.00
OptiNose (OPTN) United States $0.308B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.284B 0.00
KalVista Pharmaceuticals (KALV) United States $0.270B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.268B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.260B 0.00
Ocular Therapeutix (OCUL) United States $0.252B 0.00
MEI Pharma (MEIP) United States $0.244B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.227B 0.00
IMV INC (IMV) Canada $0.220B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.212B 0.00
Nature's Sunshine Products (NATR) United States $0.202B 34.80
Jounce Therapeutics (JNCE) United States $0.193B 2.58
Taiwan Liposome (TLC) Taiwan $0.191B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.130B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.128B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.124B 0.00
CannTrust Holdings (CTST) Canada $0.120B 0.00
Xeris Pharmaceuticals (XERS) United States $0.117B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Otonomy (OTIC) United States $0.111B 0.00
Redhill Biopharma (RDHL) Israel $0.108B 0.00
Aquestive Therapeutics (AQST) United States $0.106B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.104B 0.00
CV Sciences (CVSI) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.085B 0.00
Champions Oncology (CSBR) United States $0.082B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.078B 0.00
CTI BioPharma (CTIC) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.071B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.069B 20.68
Onconova Therapeutics (ONTX) United States $0.069B 0.00
IsoRay (ISR) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
Nivalis Therapeutics (ALPN) United States $0.058B 0.00
AgeX Therapeutics (AGE) United States $0.055B 0.00
Aclaris Therapeutics (ACRS) United States $0.055B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
VAXART, INC (VXRT) United States $0.052B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.051B 0.00
Natural Alternatives (NAII) United States $0.051B 23.00
Forward Pharma (FWP) Denmark $0.049B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.047B 0.00
PolarityTE (PTE) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.027B 0.00
PharmAthene (ALT) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
India Globalization Capital (IGC) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Cardiome Pharma (CORV) Canada $0.017B 0.00
Shineco (TYHT) China $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Vical (BBI) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Novan (NOVN) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00